bpc-157 drops bioavailability of oral bpc 157 Oral Peptides: FAQs on Bioavailability, Safety, and Clinical Use Oral Peptides: FAQs on Bioavailability, – BPC-157 LIQUID SPRAY - High

Fatigue that worsens after meals or is accompanied by abdominal discomfort may primarily reflect gastrointestinal side effects rather than a distinct energy problem

*Note: Values marked with an asterisk exceed the capacity of a standard 1 mL (100-unit) insulin syringe

This study included patients who underwent radical PG-DTR or TG for pathological stage I gastric cancer

[5] [7] At dosages exceeding 5 grams, there is a potential risk for more severe adverse effects, including renal dysfunction, blood toxicity, and neurological symptoms

But the syringe you're using has large, poorly defined markings and significant 'dead space' (the small amount of fluid left in the hub and needle after the plunger is fully depressed)